A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

NCT00150267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

976

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Xalacom

Sponsor

Pfizer